Higher TP53BP2 expression is associated with HBsAg loss in peginterferon-α-treated patients with chronic hepatitis B
Guiwen Guan(Peking University), Xiangmei Chen(Capital Medical University), Zhenzhen Zeng(First Affiliated Hospital of Zhengzhou University), Zhiliang Gao(Sun Yat-sen University), Guochao Wei(Chinese Academy of Sciences), Jing Ning(Peking University), Sujun Zheng(Beijing Tian Tan Hospital), Changyu Tao(Peking University), Ence Yang(Peking University), Fengmin Lu(Hebei Medical University), Jing Zhang(Peking University), Huili Guo(Sun Yat-sen University), Jing Yang(China Three Gorges Corporation (China)), Ren Liu(BGI Group (China)), Weilin Gu(Peking University), Na Gao(Capital Medical University), Shan Ren(Capital Medical University), Chia-Chen Chen(Peking University), Ting Zhang(Peking University), Xinyue Chen(Capital Medical University), Lin Wang(Women's Hospital, School of Medicine, Zhejiang University), Xiaosen Guo(BGI Group (China))
Cited by 27
Related Papers
A global reference for human genetic variation
|Nature|2015|19.9k
Combination of oral STING agonist MSA-2 and anti-TGF-β/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumors
|Journal of Hematology & Oncology|2022|178
TRIM38 inhibits TNFα- and IL-1β–triggered NF-κB activation by mediating lysosome-dependent degradation of TAB2/3
|Proceedings of the National Academy of Sciences|2014|151
SOX17 antagonizes WNT/β-catenin signaling pathway in hepatocellular carcinoma
|Epigenetics|2010|131